| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Serina Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 95,730 | $957,300 | $10.00 | 28 Mar 2025 | Direct |
| Serina Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 230,100 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | 03 Feb 2026 | 1 | $0 | 4 | Chief Executive Officer, Director | 17 Feb 2026, 08:20 |
| SER | Serina Therapeutics, Inc. | 28 Mar 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 01 Apr 2025, 16:06 |
| SER | Serina Therapeutics, Inc. | 09 Sep 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 11 Sep 2024, 16:30 |
| SER | AgeX Therapeutics, Inc. | 26 Mar 2024 | 0 | $0 | 3 | Interim CEO, Director | 03 Apr 2024, 20:02 |